Log in to save to my catalogue

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by...

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_25343e5b801f4662be448798ebe81a76

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Most breast cancers exhibit low immune infiltration and are unresponsive to immunotherapy. We hypothesized that inhibition of the receptor activator of nuclear factor-κB (RANK) signaling pathway may enhance immune activation. Here we report that loss of RANK signaling in mouse tumor cells increases leukocytes, lymphocytes, and CD8
+
T cells,...

Alternative Titles

Full title

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_25343e5b801f4662be448798ebe81a76

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_25343e5b801f4662be448798ebe81a76

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-020-20138-8

How to access this item